Cargando…

Posterior Reversible Encephalopathy Syndrome in a B-Cell Acute Lymphoblastic Leukemia Young Adult Patient Treated with a Pediatric-Like Chemotherapeutic Schedule

We report here the case of a young adult affected by pre B-cell acute lymphoblastic leukemia (ALL), who developed, during a pediatric-like chemotherapy consolidation schedule with high dosage of Methotrexate, a severe neurological toxicity. Clinical presentation and neuroimaging data were diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papayannidis, Cristina, Volpato, Francesca, Iacobucci, Ilaria, Abbenante, Maria Chiara, Sartor, Chiara, Martinelli, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194385/ https://www.ncbi.nlm.nih.gov/pubmed/25317320 http://dx.doi.org/10.4081/hr.2014.5565

Ejemplares similares

Rationale for a Pediatric-Inspired Approach in the Adolescent and Young Adult Population with Acute Lymphoblastic Leukemia, with a Focus on Asparaginase Treatment
por: Rizzari, Carmelo, et al.
Publicado: (2014)

Recurrent Gastrointestinal Hemorrhage in Treatment with Dasatinib in a Patient Showing SMAD4 Mutation with Acute Lymphoblastic Leukemia Philadelphia Positive and Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome
por: Sartor, Chiara, et al.
Publicado: (2013)

A Case Report of Acute Myeloid Leukemia and Neurofibromatosis 1
por: Sartor, Chiara, et al.
Publicado: (2013)

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
por: Rorà, Andrea Ghelli Luserna Di, et al.
Publicado: (2016)

The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report
por: De Benedittis, Caterina, et al.
Publicado: (2017)

Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
por: Bertamini, Luca, et al.
Publicado: (2018)

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
por: Ghelli Luserna Di Rorà, Andrea, et al.
Publicado: (2018)

A rare cause of posterior reversible encephalopathy syndrome: Acute lymphoblastic leukemia
por: Hayes, Jessica, et al.
Publicado: (2023)

Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia
por: Ravaioli, Federico, et al.
Publicado: (2021)

Isolated cerebellar involvement in posterior reversible encephalopathy syndrome in a child with acute lymphoblastic leukemia
por: Chaudhary, Narendra, et al.
Publicado: (2011)

Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients
por: Trino, Stefania, et al.
Publicado: (2016)

In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia
por: Iacobucci, Ilaria, et al.
Publicado: (2015)

Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia
por: Iacobucci, Ilaria, et al.
Publicado: (2013)

P375: INOTUZUMB OZOGAMICIN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY ACUTE B-LYMPHOBLASTIC LEUKEMIA
por: Kayser, Sabine, et al.
Publicado: (2023)

Posterior reversible encephalopathy syndrome and the pediatric population
por: Peter, Prasant, et al.
Publicado: (2012)

Posterior reversible encephalopathy syndrome in pediatric acute leukemia: Case series and literature review
por: Appachu, M. Sandhya, et al.
Publicado: (2014)

Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
por: Ghelli Luserna Di Rorà, Andrea, et al.
Publicado: (2019)

Cytogenetic and Molecular Predictors of Outcome in Acute Lymphocytic Leukemia: Recent Developments
por: Iacobucci, Ilaria, et al.
Publicado: (2012)

Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?
por: Martinelli, Giovanni, et al.
Publicado: (2009)

Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
por: Mei, Yanyan, et al.
Publicado: (2014)

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph(+) acute lymphoblastic leukemia
por: Martinelli, Giovanni, et al.
Publicado: (2022)

Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case
por: Malkan, Umit Y., et al.
Publicado: (2018)

Posterior reversible encephalopathy syndrome
por: Fischer, Marlene, et al.
Publicado: (2017)

Posterior Reversible Encephalopathy Syndrome
por: Gewirtz, Alexandra N., et al.
Publicado: (2021)

Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia
por: Bruno, Samantha, et al.
Publicado: (2019)

Acute Myeloid Leukemia Mutations: Therapeutic Implications
por: Papayannidis, Cristina, et al.
Publicado: (2019)

Posterior Reversible Encephalopathy Syndrome in Pediatric Cancer: Clinical and Radiologic Findings
por: Khan, Saadiya Javed, et al.
Publicado: (2017)

Posterior reversible encephalopathy syndrome in the pediatric population: a pictorial essay
por: Proença, Filipa, et al.
Publicado: (2022)

Posterior reversible encephalopathy syndrome and Wernicke encephalopathy in patient with acute graft-versus-host disease
por: Di Giuliano, Francesca, et al.
Publicado: (2019)

Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome postpartum
por: Nielsen, Lise Hald, et al.
Publicado: (2015)

Posterior Reversible Encephalopathy Syndrome in ALL
por: Millichap, J. Gordon
Publicado: (2015)

Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017)

Brainstem Posterior Reversible Encephalopathy Syndrome
por: Hama, Ryosuke, et al.
Publicado: (2019)

Posterior Reversible Encephalopathy Syndrome (PRES)
por: Ciozda, William, et al.
Publicado: (2020)

Malignant Posterior Reversible Encephalopathy Syndrome: A Case of Posterior Irreversible Encephalopathy Syndrome
por: Martins, William Alves, et al.
Publicado: (2016)

Posterior Reversible Encephalopathy Syndrome Triggered by Obinutuzumab in a Patient with Chronic Lymphocytic Leukemia
por: Atef, Bentolhoda, et al.
Publicado: (2023)

Wernicke’s Encephalopathy in a Child with Acute Lymphoblastic Leukemia
por: Kızılocak, Hande, et al.
Publicado: (2017)

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients
por: Zuffa, Elisa, et al.
Publicado: (2015)

IKAROS Deletions Dictate a Unique Gene Expression Signature in Patients with Adult B-Cell Acute Lymphoblastic Leukemia
por: Iacobucci, Ilaria, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h5p1onbgqr7lcq8lijt2l77s05